Insider · CIK 0001185945
RALLIS CHRIS A
Reports to the SEC for 3 companies · RESEARCH TRIANGLE PARK, NC
Transactions
50
Companies
3
Filings
8
CIK
0001185945
Forms 4 and 5
Insider transactions
| Date | Company | Value |
|---|---|---|
| 2026-06-10 | FENCFENNEC PHARMACEUTICALS INC. · Stock OptionA Award | +$174K |
| 2026-05-11 | FENCFENNEC PHARMACEUTICALS INC.M Exercise/Conversion | +$35K |
| 2026-05-11 | FENCFENNEC PHARMACEUTICALS INC.S Sale | −$58.8K |
| 2026-05-11 | FENCFENNEC PHARMACEUTICALS INC. · Stock OptionM Exercise/Conversion | −$35K |
| 2025-10-10 | FENCFENNEC PHARMACEUTICALS INC.M Exercise/Conversion | +$4,996.26 |
| 2025-10-10 | FENCFENNEC PHARMACEUTICALS INC.S Sale | −$16.4K |
| 2025-10-10 | FENCFENNEC PHARMACEUTICALS INC. · Common SharesM Exercise/Conversion | −$4,996.26 |
| 2025-07-07 | FENCFENNEC PHARMACEUTICALS INC.M Exercise/Conversion | +$4,998.45 |
| 2025-07-07 | FENCFENNEC PHARMACEUTICALS INC.S Sale | −$9,746.49 |
| 2025-07-07 | FENCFENNEC PHARMACEUTICALS INC. · Common SharesM Exercise/Conversion | −$4,998.45 |
| 2025-06-03 | FENCFENNEC PHARMACEUTICALS INC. · Stock OptionA Award | +$158K |
| 2025-04-11 | FENCFENNEC PHARMACEUTICALS INC.M Exercise/Conversion | +$4,997.9 |
| 2025-04-11 | FENCFENNEC PHARMACEUTICALS INC.S Sale | −$6,974.55 |
| 2025-04-11 | FENCFENNEC PHARMACEUTICALS INC. · Common SharesM Exercise/Conversion | −$4,997.9 |
| 2025-02-14 | FENCFENNEC PHARMACEUTICALS INC.M Exercise/Conversion | +$4,999.92 |
| 2025-02-14 | FENCFENNEC PHARMACEUTICALS INC.S Sale | −$8,088.52 |
| 2025-02-14 | FENCFENNEC PHARMACEUTICALS INC. · Common SharesM Exercise/Conversion | −$4,999.92 |
| 2024-12-02 | FENCFENNEC PHARMACEUTICALS INC.M Exercise/Conversion | +$26.9K |
| 2024-12-02 | FENCFENNEC PHARMACEUTICALS INC.S Sale | −$39.4K |
| 2024-12-02 | FENCFENNEC PHARMACEUTICALS INC. · Common SharesM Exercise/Conversion | −$26.9K |
| 2024-10-08 | FENCFENNEC PHARMACEUTICALS INC.M Exercise/Conversion | +$4,998 |
| 2024-10-08 | FENCFENNEC PHARMACEUTICALS INC.S Sale | −$6,369.18 |
| 2024-10-08 | FENCFENNEC PHARMACEUTICALS INC. · Common SharesM Exercise/Conversion | −$4,998 |
| 2024-08-15 | FENCFENNEC PHARMACEUTICALS INC. · Stock OptionA Award | +$112K |
| 2024-07-05 | FENCFENNEC PHARMACEUTICALS INC.M Exercise/Conversion | +$4,999.68 |
| 2024-07-05 | FENCFENNEC PHARMACEUTICALS INC.S Sale | −$7,073.19 |
| 2024-07-05 | FENCFENNEC PHARMACEUTICALS INC. · Common SharesM Exercise/Conversion | −$4,999.68 |
| 2024-04-15 | FENCFENNEC PHARMACEUTICALS INC.S Sale | −$8,360 |
| 2024-04-15 | FENCFENNEC PHARMACEUTICALS INC.M Exercise/Conversion | +$14.5K |
| 2024-04-15 | FENCFENNEC PHARMACEUTICALS INC. · Common SharesM Exercise/Conversion | −$5,000.4 |
| 2024-03-26 | FENCFENNEC PHARMACEUTICALS INC.S Sale | −$23.2K |
| 2024-03-26 | FENCFENNEC PHARMACEUTICALS INC.M Exercise/Conversion | +$9,999.99 |
| 2024-03-26 | FENCFENNEC PHARMACEUTICALS INC. · Common SharesM Exercise/Conversion | −$9,999.99 |
| 2023-12-26 | FENCFENNEC PHARMACEUTICALS INC.S Sale | −$15.2K |
| 2023-12-26 | FENCFENNEC PHARMACEUTICALS INC.M Exercise/Conversion | +$4,998.96 |
| 2023-12-26 | FENCFENNEC PHARMACEUTICALS INC. · Common SharesM Exercise/Conversion | −$4,998.96 |
| 2023-11-20 | FENCFENNEC PHARMACEUTICALS INC.S Sale | −$2,219.25 |
| 2023-08-18 | FENCFENNEC PHARMACEUTICALS INC.S Sale | −$5,283.05 |
| 2023-07-24 | FENCFENNEC PHARMACEUTICALS INC.M Exercise/Conversion | +$12K |
| 2023-07-24 | FENCFENNEC PHARMACEUTICALS INC.S Sale | −$55.5K |
| 2023-07-24 | FENCFENNEC PHARMACEUTICALS INC. · Common SharesM Exercise/Conversion | −$12K |
| 2023-07-06 | FENCFENNEC PHARMACEUTICALS INC.S Sale | −$18.7K |
| 2023-07-06 | FENCFENNEC PHARMACEUTICALS INC.M Exercise/Conversion | +$5,068.8 |
| 2023-07-06 | FENCFENNEC PHARMACEUTICALS INC. · Common SharesM Exercise/Conversion | −$4,999.68 |
| 2023-06-12 | FENCFENNEC PHARMACEUTICALS INC. · Stock OptionA Award | — |
| 2023-05-19 | FENCFENNEC PHARMACEUTICALS INC.S Sale | −$6,130.88 |
| 2023-05-19 | FENCFENNEC PHARMACEUTICALS INC.S Sale | −$6,808 |
| 2023-04-17 | FENCFENNEC PHARMACEUTICALS INC.M Exercise/Conversion | +$4,998 |
| 2023-04-17 | FENCFENNEC PHARMACEUTICALS INC.F Tax Payment | −$8,223.24 |
| 2023-03-03 | FENCFENNEC PHARMACEUTICALS INC.M Exercise/Conversion | +$9,998.4 |
Recent filings
- 4RALLIS CHRIS A0001185945-26-000004SEC(opens sec.gov)
- 4RALLIS CHRIS A0001185945-26-000002SEC(opens sec.gov)
- 4RALLIS CHRIS A0001185945-25-000005SEC(opens sec.gov)
- 4RALLIS CHRIS A0001415889-25-019433SEC(opens sec.gov)
- 4RALLIS CHRIS A0001415889-25-015587SEC(opens sec.gov)
- 4RALLIS CHRIS A0001415889-25-010574SEC(opens sec.gov)
- 4RALLIS CHRIS A0001415889-25-004249SEC(opens sec.gov)
- 4RALLIS CHRIS A0001415889-24-028018SEC(opens sec.gov)
Companies
Address
C/O FENNEC PHARMACEUTICALS, INC. PO BOX 13628, 68 TW ALEXANDER DRIVE
RESEARCH TRIANGLE PARK, NC, 27709